Track Outset Medical, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Outset Medical, Inc. OM · Stock Open Outset Medical, Inc. in new tab

3.73 USD
EPS
-3.78
P/B
0.93
ROE
-63.04
Beta
1.92
Target Price
7.67 USD
Outset Medical, Inc. logo

Outset Medical, Inc.

🧾 Earnings Recap – Q2 2026

Shares declined 4.3% as investors reacted negatively to deceleration in product and consumable revenue growth and a cautious outlook implied by muted full-year guidance reaffirmation amidst challenging comps.

  • Revenue rose 1% year-over-year to $31.6 million, reflecting minimal top-line growth.
  • Product revenue declined 5% year-over-year, pressured by a 12% drop in consumables despite a 6% increase in console sales.
  • Service and other revenue grew 17%, driven by volume and price increases, partially offsetting weakness in product segments.
  • Gross margin improved to 42% on a non-GAAP basis, reflecting ongoing margin expansion efforts.
  • Full-year 2026 revenue guidance was reiterated at $125 million to $130 million, signaling cautious expectations without upward revision.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 10, 2027
EPS-3.78
Book Value4.41
Price to Book0.93
Debt/Equity125.76
% Insiders5.433%
Growth
Revenue Growth0.14%
Estimates
Forward P/E-1.78
Forward EPS-2.32
Target Mean Price7.67

DCF valuation

Model fair value for Outset Medical, Inc. (OM)
Result
Sign in to run the valuation for OM.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
3 analysts · consensus Buy · mean target 7.67 USD (low 6.00, high 10.00) · as of 10 Nov 2026
Low 6.00
Mean 7.67
High 10.00
Price 3.73
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Outset Medical, Inc. Logo Outset Medical, Inc. Analysis (OM)

United States Health Care Official Website Stock

Is Outset Medical, Inc. a good investment? Outset Medical, Inc. (OM) is currently trading at 3.73 USD. Market analysts have a consensus price target of 7.67 USD. This suggests a potential upside from current levels.

Earnings Schedule: Outset Medical, Inc. is expected to release its next earnings report on Feb. 10, 2027. The market consensus estimate for Forward EPS is -2.32.

Investor FAQ

Does Outset Medical, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Outset Medical, Inc.?

Outset Medical, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 10, 2027. The company currently has a trailing EPS of -3.78.

Company Profile

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Exchange Ticker
NMS (United States) OM
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
March 20, 2025 0.07
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion